Logo image of ZVIA

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

NYSE:ZVIA - New York Stock Exchange, Inc. - US98955K1043 - Common Stock - Currency: USD

2.02  -0.07 (-3.35%)

After market: 2.02 0 (0%)

Fundamental Rating

3

Overall ZVIA gets a fundamental rating of 3 out of 10. We evaluated ZVIA against 32 industry peers in the Beverages industry. While ZVIA has a great health rating, there are worries on its profitability. ZVIA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ZVIA had negative earnings in the past year.
ZVIA had a negative operating cash flow in the past year.
ZVIA had negative earnings in each of the past 5 years.
ZVIA had a negative operating cash flow in each of the past 5 years.
ZVIA Yearly Net Income VS EBIT VS OCF VS FCFZVIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -29.44%, ZVIA is not doing good in the industry: 84.38% of the companies in the same industry are doing better.
ZVIA's Return On Equity of -30.83% is on the low side compared to the rest of the industry. ZVIA is outperformed by 78.13% of its industry peers.
Industry RankSector Rank
ROA -29.44%
ROE -30.83%
ROIC N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ZVIA Yearly ROA, ROE, ROICZVIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

ZVIA has a Gross Margin (46.39%) which is comparable to the rest of the industry.
ZVIA's Gross Margin has been stable in the last couple of years.
ZVIA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
ZVIA Yearly Profit, Operating, Gross MarginsZVIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

8

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZVIA has been increased compared to 1 year ago.
Compared to 5 years ago, ZVIA has more shares outstanding
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZVIA Yearly Shares OutstandingZVIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZVIA Yearly Total Debt VS Total AssetsZVIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ZVIA has an Altman-Z score of 29.70. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.
ZVIA has a Altman-Z score of 29.70. This is amongst the best in the industry. ZVIA outperforms 100.00% of its industry peers.
ZVIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 29.7
ROIC/WACCN/A
WACC9%
ZVIA Yearly LT Debt VS Equity VS FCFZVIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 2.56 indicates that ZVIA has no problem at all paying its short term obligations.
ZVIA's Current ratio of 2.56 is fine compared to the rest of the industry. ZVIA outperforms 71.88% of its industry peers.
A Quick Ratio of 1.79 indicates that ZVIA should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.79, ZVIA belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.79
ZVIA Yearly Current Assets VS Current LiabilitesZVIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.19% over the past year.
The Revenue has decreased by -6.83% in the past year.
Measured over the past years, ZVIA shows a quite strong growth in Revenue. The Revenue has been growing by 12.62% on average per year.
EPS 1Y (TTM)26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%4.4%

3.2 Future

The Earnings Per Share is expected to grow by 19.44% on average over the next years. This is quite good.
Based on estimates for the next years, ZVIA will show a small growth in Revenue. The Revenue will grow by 6.66% on average per year.
EPS Next Y25.97%
EPS Next 2Y25.17%
EPS Next 3Y19.44%
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2Y5.38%
Revenue Next 3Y6.66%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZVIA Yearly Revenue VS EstimatesZVIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ZVIA Yearly EPS VS EstimatesZVIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ZVIA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ZVIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZVIA Price Earnings VS Forward Price EarningsZVIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZVIA Per share dataZVIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ZVIA's earnings are expected to grow with 19.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.17%
EPS Next 3Y19.44%

More info and screens

0

5. Dividend

5.1 Amount

ZVIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEVIA PBC-A

NYSE:ZVIA (5/6/2025, 5:05:00 PM)

After market: 2.02 0 (0%)

2.02

-0.07 (-3.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-26 2025-02-26/bmo
Earnings (Next)05-07 2025-05-07/amc
Inst Owners50.41%
Inst Owner Change0.01%
Ins Owners4.23%
Ins Owner Change1.97%
Market Cap149.92M
Analysts78.33
Price Target4.25 (110.4%)
Short Float %1.87%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.95%
Min EPS beat(2)-12.04%
Max EPS beat(2)49.94%
EPS beat(4)3
Avg EPS beat(4)15.49%
Min EPS beat(4)-12.04%
Max EPS beat(4)49.94%
EPS beat(8)7
Avg EPS beat(8)23.51%
EPS beat(12)10
Avg EPS beat(12)18.67%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.42%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-1.79%
Revenue beat(4)1
Avg Revenue beat(4)-3.14%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)1.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.12%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.76%
EPS NY rev (1m)0%
EPS NY rev (3m)0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 2.31
P/tB 2.43
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS2.09
BVpS0.87
TBVpS0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.44%
ROE -30.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.39%
FCFM N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.29%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.56
Quick Ratio 1.79
Altman-Z 29.7
F-Score4
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)104.57%
Cap/Depr(5y)142.96%
Cap/Sales(3y)0.92%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y25.97%
EPS Next 2Y25.17%
EPS Next 3Y19.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.83%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%4.4%
Revenue Next Year3.68%
Revenue Next 2Y5.38%
Revenue Next 3Y6.66%
Revenue Next 5YN/A
EBIT growth 1Y25.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.41%
EBIT Next 3Y28.52%
EBIT Next 5YN/A
FCF growth 1Y92.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.74%
OCF growth 3YN/A
OCF growth 5YN/A